Literature DB >> 29954721

Procedural, Functional and Prognostic Outcomes Following Recanalization of Coronary Chronic Total Occlusions. Results of the Iberian Registry.

Ignacio J Amat-Santos1, Victoria Martin-Yuste2, José Antonio Fernández-Díaz3, Javier Martin-Moreiras4, Juan Caballero-Borrego5, Pablo Salinas6, Soledad Ojeda7, Fernando Rivero8, Julio Núñez Villota9, Mohsen Mohandes10, Daniela Dubois11, Francisco Bosa Ojeda12, Eva Rumiz13, José M de la Torre Hernández14, Jesús Jiménez-Mazuecos15, Javier Lacunza16, Paula Tejedor17, Itziar Gómez18, Luis R Goncalves-Ramirez18, Paol Rojas18, Manel Sabaté2, Javier Goicolea3, Alejandro Diego Nieto4, Miriam Jiménez-Fernández5, Javier Escaned6, Nieves Gonzalo6, Laura Pardo7, Javier Cuesta8, Gema Miñana9, Juan Sanchis9, Sergio Rojas10, Raúl Millán11, Beatriz Vaquerizo11, Sara Rodríguez12, Dae-Hyun Lee14, Francisco J Morales19, Alejandro Gutiérrez20, María López21, Jaume Maristany22, Juan Rondán23, Guillermo Galeote24, Zuheir Kabbanni25, Sergio Rodríguez26, Luis Teruel27, Mario Sadaba28, Alfonso Jurado29, Vicente Mainar30, Juan Sánchez-Rubio31, Hugo Vinhas32, Renato Fernandes33.   

Abstract

INTRODUCTION AND
OBJECTIVES: There is current controversy regarding the benefits of percutaneous recanalization (PCI) of chronic total coronary occlusions (CTO). Our aim was to determine acute and follow-up outcomes in our setting.
METHODS: Two-year prospective registry of consecutive patients undergoing PCI of CTO in 24 centers.
RESULTS: A total of 1000 PCIs of CTO were performed in 952 patients. Most were symptomatic (81.5%), with chronic ischemic heart disease (59.2%). Previous recanalization attempts had been made in 15%. The mean SYNTAX score was 19.5 ± 10.6 and J-score was > 2 in 17.3%. A retrograde procedure was performed in 92 patients (9.2%). The success rate was 74.9% and was higher in patients without previous attempts (82.2% vs 75.2%; P = .001), those with a J-score ≤ 2 (80.5% vs 69.5%; P = .002), and in intravascular ultrasound-guided PCI (89.9% vs 76.2%, P = .001), which was an independent predictor of success. In contrast, severe calcification, length > 20mm, and blunt proximal cap were independent predictors of failed recanalization. The rate of procedural complications was 7.1%, including perforation (3%), myocardial infarction (1.3%), and death (0.5%). At 1-year of follow-up, 88.2% of successfully revascularized patients showed clinical improvement (vs 34.8%, P < .001), which was associated with lower mortality. At 1-year of follow-up, the mortality rate was 1.5%.
CONCLUSIONS: Compared with other national registries, patients in the Iberian registry undergoing PCI of a CTO showed similar complexity, success rate, and complications. Successful recanalization was strongly associated with functional improvement, which was related to lower mortality.
Copyright © 2018. Published by Elsevier España, S.L.U.

Entities:  

Keywords:  CTO; Cardiopatía isquémica crónica; Chronic ischemic cardiomyopathy; Chronic total occlusions; IVUS; OCT; Oclusiones crónicas

Mesh:

Year:  2018        PMID: 29954721     DOI: 10.1016/j.rec.2018.05.020

Source DB:  PubMed          Journal:  Rev Esp Cardiol (Engl Ed)        ISSN: 1885-5857


  3 in total

1.  Surgical management of iatrogenic coronary artery perforations: when percutaneous treatment fails.

Authors:  Carlotta Brega; Angelo Pisani; Wael Braham; Patrick Nataf
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2020-01-03

2.  A novel real-time intravascular ultrasound double-lumen microcatheter for recanalization of chronic total occlusion: a case report.

Authors:  Yanzhuo Ma; Yuhong Peng; Gang Wang; Leisheng Ru
Journal:  J Med Case Rep       Date:  2019-10-23

3.  Choice of CTO scores to predict procedural success in clinical practice. A comparison of 4 different CTO PCI scores in a comprehensive national registry including expert and learning CTO operators.

Authors:  Pablo Salinas; Nieves Gonzalo; Víctor H Moreno; Manuel Fuentes; Sandra Santos-Martinez; José Antonio Fernandez-Diaz; Ignacio J Amat-Santos; Francisco Bosa Ojeda; Juan Caballero Borrego; Javier Cuesta; José María de la Torre Hernández; Alejandro Diego-Nieto; Daniela Dubois; Guillermo Galeote; Javier Goicolea; Alejandro Gutiérrez; Miriam Jiménez-Fernández; Jesús Jiménez-Mazuecos; Alfonso Jurado; Javier Lacunza; Dae-Hyun Lee; María López; Fernando Lozano; Javier Martin-Moreiras; Victoria Martin-Yuste; Raúl Millán; Gema Miñana; Mohsen Mohandes; Francisco J Morales-Ponce; Julio Núñez; Soledad Ojeda; Manuel Pan; Fernando Rivero; Javier Robles; Sergio Rodríguez-Leiras; Sergio Rojas; Juan Rondán; Eva Rumiz; Manel Sabaté; Juan Sanchís; Beatriz Vaquerizo; Javier Escaned
Journal:  PLoS One       Date:  2021-04-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.